Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cardiovascular Drug Reviews
Cardiovascular Drug Reviews is not currently indexed in Scopus. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 0897-5957Verify ISSN ↗1527-3466Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Cardiovascular Drug Reviews indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1983–2007).
What is the impact factor of Cardiovascular Drug Reviews?
Cardiovascular Drug Reviews has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Cardiovascular Drug Reviews and what is its ISSN?
Cardiovascular Drug Reviews is published by John Wiley and Sons Inc. Its print ISSN is 0897-5957 and its online ISSN is 1527-3466.
Is Cardiovascular Drug Reviews in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Cardiovascular Drug Reviews open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Cardiovascular Drug Reviews for 25 years, between 1983 and 2007. Coverage ended in 2007, 19 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 698 works and 14,267 citations for the title. OpenAlex attributes papers to this title as late as 2015, 8 years after Scopus coverage ended in 2007. That may reflect a changed ISSN or merged records rather than continued publishing, so confirm the journal's current status directly before submitting.
How well cited is Cardiovascular Drug Reviews? — open metrics via OpenAlex
Cardiovascular Drug Reviews has an h-index of 61 and a 2-year mean of 0 citations per paper (OpenAlex).
Cardiovascular Drug Reviews published 1 papers in 2010; its busiest recent year was 2006 with 46. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Cardiovascular Drug Reviews? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2007. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2007
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from John Wiley and Sons Inc
John Wiley and Sons Inc has 529 other titles in our data; 451 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.